CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-03-16 | Goddard Glenn Senior Vice President, Finance | Sale | −10,000 | $106.24 | $1.1M | 0 |
| 2015-03-16 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −455 | 120,814 | ||
| 2015-03-16 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −3,477 | 117,337 | ||
| 2015-03-16 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −6,068 | 111,269 | ||
| 2015-03-16 | Biller Scott Chief Scientific Officer | Exercise or conversion | +5,500 | $0.47 | $3K | 48,270 |
| 2015-03-16 | Biller Scott Chief Scientific Officer | Sale | −5,500 | $106.81 | $587K | 42,770 |
| 2015-03-16 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −5,500 | 302,817 | ||
| 2015-03-12 | Schenkein David P Chief Executive Officer | Gift | −190 | 94,511 | ||
| 2015-03-05 | Schenkein David P Chief Executive Officer | Sale | −2,600 | $110.16 | $286K | 102,501 |
| 2015-03-02 | Biller Scott Chief Scientific Officer | Grant or award · Stock option (right to buy) | +68,000 | 308,317 | ||
| 2015-03-02 | Goddard Glenn Senior Vice President, Finance | Grant or award · Stock option (right to buy) | +30,600 | 121,269 | ||
| 2015-03-02 | Higgons John Duncan Chief Operating Officer | Grant or award · Stock Option (right to buy) | +68,000 | 365,022 | ||
| 2015-02-27 | Biller Scott Chief Scientific Officer | Grant or award | +270 | $39.35 | $11K | 42,770 |
Page 93 of 93 · 1,853 trades